Ten Hot Topics in Head and Neck Surgical Oncology

Sunday, October 1, 2023

5:00 PM - 6:00 PM East Coast USA Time

Location: Ballroom C2

Moderator(s)

John D. Cramer, MD

Associate Professor
Wayne State University School of Medicine
Detroit, MI, United States

Panelist(s)

Evan Michael Graboyes, MD, MPH, FACS

Associate Professor
Medical University of South Carolina
Charleston, SC, United States
Daniel L. Faden, MD

Assistant Professor
Department of Otolaryngology–Head and Neck Surgery Harvard Medical School
Boston, MA, United States
Leila J. Mady, MD PhD MPH

Assistant Professor
Johns Hopkins University
Baltimore, MD, United States

Disclosure(s):

John D. Cramer, MD: No relevant relationships to disclose.

Evan Michael Graboyes, MD, MPH, FACS: No relevant relationships to disclose.

Daniel L. Faden, MD: No relevant relationships to disclose.

Leila J. Mady, MD PhD MPH: No relevant relationships to disclose.

PROGRAM DESCRIPTION: This panel is a rapid fire/quick shot session that will cover ten hot topics related to head and neck surgical oncology. Our goal is to quickly cover a diverse set of recent practice changing clinical trials that are important for decision making in tumor boards. This panel will cover major developments across a diverse range of head and neck cancers. This is intended for trainees or general otolaryngologists. The topics covered will include neoadjuvant versus adjuvant immunotherapy for cutaneous malignancies, changes in adjuvant therapy for HPV-associated cancers, molecular surveillance for HPV-associated cancers, and genetic testing for various head and neck cancers.

OUTCOME OBJECTIVE 1: Understand how to integrate surgery with adjuvant or neoadjuvant therapy based on recent clinical trials

OUTCOME OBJECTIVE 2: Recognize the role of circulating tumor DNA testing in routine clinical practice

OUTCOME OBJECTIVE 3: Understand roles of genetic testing in clinical practice of various head and neck cancers

BACKGROUND STATEMENT: With the explosion of molecular advances, immunotherapy and targeted agents in the treatment of various different types of head and neck there is rapidly emerging data regarding effective incorporation in treatment. We will review a number of recent landmark clinical trials.